AbbVie Inc. (ABBV) Stock Overview
NYSE · Healthcare · Drug Manufacturers - General
About AbbVie Inc.
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the…
Source: Yahoo Finance
Sector & Industry
AbbVie Inc. operates in the Healthcare sector, within the Drug Manufacturers - General industry group. It is listed on the NYSE exchange.
AbbVie Inc. at a Glance
| Company | AbbVie Inc. |
| Ticker | ABBV |
| Exchange | NYSE |
| Currency | USD |
| Price | $254.49 |
| Market cap | $449.63B |
| P/E ratio (trailing) | 124.75 |
| EPS (trailing) | $2.04 |
| 52-week high | $261.64 |
| 52-week low | $184.63 |
| Dividend yield | 2.72% |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Employees | 57,000 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →A practical framework for judging whether a dividend is safe and worth owning.
Check Price →Top-rated books on building an income portfolio from dividend payers.
Check Price →Frequently Asked Questions
What is AbbVie Inc.'s P/E ratio?
AbbVie Inc. (ABBV) has a trailing P/E ratio of 124.75 as of our latest data snapshot.
What is AbbVie Inc.'s market cap?
AbbVie Inc.'s market capitalisation is $449.63B based on the most recent snapshot.
What is ABBV's 52-week range?
Over the past 52 weeks, ABBV has traded between $184.63 and $261.64.
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Related Healthcare Stocks
Data snapshot: 18 July 2026 (Yahoo Finance) · Page last built: